Literature DB >> 33073522

Current Advances on 3D-Bioprinted Liver Tissue Models.

Liang Ma1,2, Yutong Wu1,2, Yuting Li1,2, Abdellah Aazmi1,2, Hongzhao Zhou1,2, Bin Zhang1,2, Huayong Yang1,2.   

Abstract

The liver, the largest gland in the human body, plays a key role in metabolism, bile production, detoxification, and water and electrolyte regulation. The toxins or drugs that the gastrointestinal system absorbs reach the liver first before entering the bloodstream. Liver disease is one of the leading causes of death worldwide. Therefore, an in vitro liver tissue model that reproduces the main functions of the liver can be a reliable platform for investigating liver diseases and developing new drugs. In addition, the limitations in traditional, planar monolayer cell cultures and animal tests for evaluating the toxicity and efficacy of drug candidates can be overcome. Currently, the newly emerging 3D bioprinting technologies have the ability to construct in vitro liver tissue models both in static scaffolds and dynamic liver-on-chip manners. This review mainly focuses on the construction and applications of liver tissue models based on 3D bioprinting. Special attention is given to 3D bioprinting strategies and bioinks for constructing liver tissue models including the cell sources and hydrogel selection. In addition, the main advantages and limitations and the major challenges and future perspectives are discussed, paving the way for the next generation of in vitro liver tissue models.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  3D bioprinting; bioinks; hepatocytes; liver in vitro models; liver-on-chips

Mesh:

Substances:

Year:  2020        PMID: 33073522     DOI: 10.1002/adhm.202001517

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  13 in total

Review 1.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

2.  Bioengineering of the liver.

Authors:  Alberto Redaelli; Mian Long
Journal:  APL Bioeng       Date:  2022-04-01

Review 3.  Review on Multicomponent Hydrogel Bioinks Based on Natural Biomaterials for Bioprinting 3D Liver Tissues.

Authors:  Daekeun Kim; Minseok Kim; Jongwan Lee; Jinah Jang
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14

Review 4.  The Hitchhiker's Guide to Human Therapeutic Nanoparticle Development.

Authors:  Thelvia I Ramos; Carlos A Villacis-Aguirre; Katherine V López-Aguilar; Leandro Santiago Padilla; Claudia Altamirano; Jorge R Toledo; Nelson Santiago Vispo
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

Review 5.  Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review.

Authors:  Qingfei Chu; Xinyu Gu; Qiuxian Zheng; Haihong Zhu
Journal:  Ann Transl Med       Date:  2022-01

Review 6.  Vascularizing the brain in vitro.

Authors:  Abdellah Aazmi; Hongzhao Zhou; Weikang Lv; Mengfei Yu; Xiaobin Xu; Huayong Yang; Yu Shrike Zhang; Liang Ma
Journal:  iScience       Date:  2022-03-17

Review 7.  In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications.

Authors:  Maria Jimenez Ramos; Lucia Bandiera; Filippo Menolascina; Jonathan Andrew Fallowfield
Journal:  iScience       Date:  2021-12-04

Review 8.  The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities.

Authors:  Eleonora Binatti; Alessio Gerussi; Donatella Barisani; Pietro Invernizzi
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

9.  Bioprinting of a Hepatic Tissue Model Using Human-Induced Pluripotent Stem Cell-derived Hepatocytes for Drug-Induced Hepatotoxicity Evaluation.

Authors:  Jianyu He; Jinglin Wang; Yuan Pang; Hang Yu; Xueqian Qin; Ke Su; Tao Xu; Haozhen Ren
Journal:  Int J Bioprint       Date:  2022-06-14

10.  Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State.

Authors:  Hyun Kyoung Kang; Madina Sarsenova; Da-Hyun Kim; Min Soo Kim; Jin Young Lee; Eun-Ah Sung; Myung Geun Kook; Nam Gyo Kim; Soon Won Choi; Vyacheslav Ogay; Kyung-Sun Kang
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.